Services

Theragen Bio NGS Service

Theragen Bio,established in 2009 as a research institute within Theragen Etex and has accumulated world-class capabilities over the past 10 years.
We provide genomic analysis services to over 700 medical institutions in Korea and more than 40 research institutions abroad.
In addition, we completed the human genome map In Korea initially and participated in research on the evolution of ancient Ethiopian genomes.Based on our accumulated expertise,Theragen Bio provide Best-in-classNext-Generation Sequencing (NGS) services to our partners.

Brochure (KOR)Brochure (ENG)

Click on each button to move to the corresponding page.

DNA Sequencing
(WGS/Target Seq)
Transcriptome Sequencing
Single cell RNA-Sequencing
Spatial Sequencing
Epigenome Sequencing
Metagenome Sequencing
SNP Array

NGS Sequencing +
Bioinformatics

DNA Sequencing (WGS/Target Seq)

Whole Genome De novo Sequencing

Transcriptome Sequencing

Single-cell RNA Sequencing

GeoMx®

Epigenome Sequencing

Metagenome Sequencing

SNP Array

Global Innovative
Genome Service Provider

Clinical Analysis

Clinical Trial Sample Analysis

FFPE specimen and biomarker discovery

Companion diagnostics development.

1Why Theragen?

Accumulated Technical Capabilities

Since its establishment as Theragen Bio Research Institute in 2009, we firstly have completed the human genome map as well as
the standard genome maps of the tiger, minke whale, and eagle In 2017, we also received approval as
the first NGS clinical laboratory in Korea from the Ministry of Food and Drug Safety(MFDS).

  • No.1

    Have No.1 NGS data production and processing system in Korea.(5pb data output in Korea)

  • 27

    A total of 27 patent registrations, including 10 patent registrations related to large-scale genomic big data.

  • 60

    Number of service products that have commercialized self-developed products such as customized treatment screening tests, companion diagnostics, liquid biopsy and others.

  • 50

    Carried out a total of 50 key national tasks, including K-DNA business and healthcare big data constructions

  • 150

    More than 150 papers published in SCI-class major journals.

  • 95

    A total of  95 patents
    applications, including 3 new
    antigen prediction patents
    and 5 genomic data patents.

  • 25%

    Secured customers from 700
    domestic medical institutions,
    occupying a market share of
    about 25% in the domesitc
    markter, and providing services to customers 40 overseas countries.

  • Good Clinical Laboratory Practice certificate

    Good Clinical Laboratory Practice certificate

  • In vitro diagnostic test certificate of clinical laboratory

    In vitro diagnostic test certificate of clinical laboratory

  • Genetic Testing Accuracy Evaluation Certification

    Genetic Testing Accuracy Evaluation Certification

  • ISO9001

    ISO9001

  • ISO 27701

    ISO 27701

  • ISO 27001

    ISO 27001

2Why Theragen?

Specialized bioinformatics analysis

Theragen Bio provides high-quality bioinformatics analysis results, utilizing its expertise in developing the genomic big data service, DEEPOMICS®.
A dedicated manager will be involved throughout the entire process of deriving web-based analysis results.

DEEPOMICS®, developed by Theragen Bio, is a patient-specific diagnosis and prognosis analysis platform based on AI for genomic big data services. It consists of four platforms: DEEPOMICS® NEO for cancer vaccine research and development, DEEPOMICS® MARKER for analyzing individual patient's concurrent symptoms and prognosis, DEEPOMICS® NETWORK for analyzing patient's drug interactions, and DEEPOMICS® TARGET for selecting effective drug targets for treatment.

  • Theragenbio BI pipeline

    Theragenbio BI pipeline

  • Analysis Result

    Analysis Result

3Why Theragen?

Various and demanding samples Prep/QC

We have our own BIO IT solution (NGS LIMS) and provide high-quality analysis by integrating it in real-time with the entire experimental process.
We have extensive experience in handling various challenging samples, such as specific animal tissues, plants with high levels of polysaccharides, endangered species, and clinical samples with very low amounts of material. Our accumulated experience enables us to provide accurate and reliable results.

다양하고 까다로운 샘플 Prep/QC

Sequencing Platform

NovaseqX NovaSeq 6000 HiSeq 4000 HiSeq 2500
Figure NovaseqX NovaSeq 6000 HiSeq 4000 HiSeq 2500
InstrumentDimension 34" × 36.7" × 62.5"
(86.4cm × 93.3cm × 158.8cm)		 31.5" × 37.2" × 65.2"
(80cm × 94.5cm × 165.6cm)		 46.7" × 30" × 37"
(118.6cm × 76cm × 94cm)		 46.7" × 30" × 37"
(118.6cm × 76cm × 94cm)
Workflow Library Prep
> Sequence
> Analyze		 Library Prep
> Sequence
> Analyze		 Library Prep
> Sequence
> Analyze		 Library Prep> Sequence> Analyze
Capable Experiment Total/Targeted DNA seqWhole Genome Sequencing,Whole Exome seq,Whole-Transcriptome Seq,de novo Seq,Epigenetic regulationRNA-Seq, mRNA-Seq,Amplicon Sequencing,Genotyping by Sequencing,Metagenomics, MeDIP-Seq,ChIP-Seq, Methyl-Seq WGS,Whole Exome seq,Whole-Transcriptome seq Next Gen Sequencing,Whole Genome Sequencing,Exome Sequencing,RNA-Seq, mRNA-Seq,Targeted Sequencing,Amplicon Sequencing,Genotyping by Sequencing,Metagenomics, MeDIP-Seq,ChIP-Seq, Methyl-Seq Exome seq,Whole-Transcriptome Seq,de novo Seq,Epigenetic regulation
Explanation

Our new sequencing platform has increased throughput by 2.5 times compared to the previous NovaSeq 6000

while reducing the sequencing time from 48 hours to 24 hours, halving the time required.

This increased throughput enables us to generate over 20,000 whole genome sequences per year, surpassing our previous sequencing platform's capacity.

 Up to 6Tb and 20 billion cell analyses in 44 hours 3 billion pairs of Whole genome sequencing in 3.5 days, 180 exosomes in 2 days, or 100 messenger RNA sequencing data can be produced at once. High-quality data delivery using SBS technology, sequencing equipment that allows flexible use of multiple applications
MiSeqDx Ion S5 XL Sequencer Ion Proton Sequencer GeoMx® Digital Spatial Profiler Sequel Ⅱ
Figure MiSeqDx Ion S5 XL Sequencer Ion Proton Sequencer GeoMx® Digital Spatial Profiler Sequel Ⅱ
Instrument Dimension 27" × 22.2" × 20.6"
(68.6cm × 56.5cm × 52.3cm)		 8.5" × 22.3" × 22.3"
(21.6cm × 56.6cm × 56.6cm)		 21.3" × 30.5" × 18.7"
(54.2cm × 77.5cm × 47.4cm)		 30" × 29" × 24"
(76.2cm × 73.7 × 61cm)		 72" × 14" × 13"
(182.9cm × 35.6cm × 33cm)
Workflow Library Prep
> Sequence
> Analyze		 Library Prep
> Sequence
> Analyze		 Construct library
> Prepare templete
> Run sequence
> Analyze data		 Sample Prep
> Image and Profile
> Count
> Analyze		 Library Prep
> SMRT Sequence
> Data Analyze
Capable Experiment Targeted DNA seq Transcriptome seq,Exome seq,Targeted seq Agricultural research,Cancer research,Forensic analysis,Human Genome Studies,Stem cell analysis Whole TranscriptomeSequencing GS, RNA seq,Targeted seq, complexpopulations,Epigenetics
Explanation A sequencing device designed by combining the SBS technology of Illumina. Offers a wide range of high-throughput sequencing applications, from microbial genomes, exomes and transcripts Equipment designed for high sequencing throughput of exosomes, transcriptomes, and genomes DIGITAL Spatial Profiler equipment capable of analyzing RNA and protein expression and all transcriptome analysis by interlocking with NGS system Suitable for Whole genome de novo assembly and Full-length 16S rRNA microbiome analysis

NGS Service Workflow

1

Consultation and Quotation Issuance

Assignment of dedicated service manager after requesting analysis service
(contact@theragenbio.com)

Based on professional service manager consultation
and referral Issuance of an estimate

2

Sample Submission

Sample submission based on test request form

Packaged sample submission

3

Sample QC

Providing QC data for the samples

Confirmation of experiment and detailed test request form (TAT confirmation)

Prep QC at the same level as Library QC

Various and rigorous sample Prep QC

4

Library preparation sequencing

Library preparation tailored to each analysis item

Conducting experiments and
sequencing for optimized results

5

Bioinformatics analysis

Web-based data analysis through
Theragen Bio's own pipeline

6

Providing Final Data Analysis Report

Sending analysis result data through
web-based platform

Contact

Service Department Phone number Email
NGS Genome Business

031-288-1276
Bioinformatics
Healthcare Healthcare Business
Customer Center
1522-2375
DTC Healthcare Service
031-288-1272
Cancer/Disease Prediction Service
031-288-1273
PR/Advertising PR

1522-2382
Etc. etc.
FAQ
Close